nitrobenzylthioinosine 5'-monophosphate has been researched along with Leishmaniasis in 1 studies
*Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL). [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, JI; Cotrim, PC; Ramos, DC; Yamashiro-Kanashiro, EH | 1 |
1 other study(ies) available for nitrobenzylthioinosine 5'-monophosphate and Leishmaniasis
| Article | Year |
|---|---|
Efficacy of the tubercidin antileishmania action associated with an inhibitor of the nucleoside transport.
Topics: Animals; Antiparasitic Agents; Cells, Cultured; Drug Therapy, Combination; Enzyme Inhibitors; Leishmania; Leishmaniasis; Macrophages; Mice; Mice, Inbred BALB C; Schistosoma mansoni; Thioinosine; Thionucleotides; Trypanosoma brucei gambiense; Tubercidin | 2009 |